Literature DB >> 12716429

Facilitation of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate receptor transmission in the suprachiasmatic nucleus by aniracetam enhances photic responses of the biological clock in rodents.

Takahiro Moriya1, Masayuki Ikeda, Koji Teshima, Reiko Hara, Koji Kuriyama, Tohru Yoshioka, Charles N Allen, Shigenobu Shibata.   

Abstract

This study was designed to test whether the alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate (AMPA) receptor-facilitating drug, aniracetam, could potentiate photic responses of the biological clock in the suprachiasmatic nucleus (SCN) of rodents. Using the whole-cell patch technique, we first demonstrated that AMPA currents elicited by either local AMPA application or optic chiasm stimulation were augmented by aniracetam in the neurons of the SCN. The AMPA application-elicited increase of intracellular Ca2+ concentration in SCN slices was also enhanced by aniracetam treatment. The systemic injection of aniracetam dose-dependently (10-100 mg/kg) potentiated the phase delay in behavioral rhythm induced by brief light exposure of low intensity (3 lux) but not high intensity (10 or 60 lux) during early subjective night. Under the blockade of NMDA receptors by (+) MK801, aniracetam failed to potentiate a light (3 lux)-induced phase delay in behavioral rhythm. Aniracetam increased the photic induction of c-Fos protein in the SCN that was elicited by low intensity light exposure (3 lux). These results suggest that AMPA receptor-mediated responses facilitated by aniracetam can explain enhanced photic responses of the biological clock in the SCN of rodents.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12716429     DOI: 10.1046/j.1471-4159.2003.01758.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  7 in total

1.  Retinohypothalamic tract synapses in the rat suprachiasmatic nucleus demonstrate short-term synaptic plasticity.

Authors:  Mykhaylo G Moldavan; Charles N Allen
Journal:  J Neurophysiol       Date:  2010-03-10       Impact factor: 2.714

2.  Role for the NR2B subunit of the N-methyl-D-aspartate receptor in mediating light input to the circadian system.

Authors:  L M Wang; A Schroeder; D Loh; D Smith; K Lin; J H Han; S Michel; D L Hummer; J C Ehlen; H E Albers; C S Colwell
Journal:  Eur J Neurosci       Date:  2008-04       Impact factor: 3.386

3.  Activation of AMPA receptors in the suprachiasmatic nucleus phase-shifts the mouse circadian clock in vivo and in vitro.

Authors:  Yasutaka Mizoro; Yoshiaki Yamaguchi; Rena Kitazawa; Hiroyuki Yamada; Masahiro Matsuo; Jean-Michel Fustin; Masao Doi; Hitoshi Okamura
Journal:  PLoS One       Date:  2010-06-03       Impact factor: 3.240

4.  Circadian Regulation of GluA2 mRNA Processing in the Rat Suprachiasmatic Nucleus and Other Brain Structures.

Authors:  Hana Míková; Viktor Kuchtiak; Irena Svobodová; Veronika Spišská; Dominika Pačesová; Aleš Balík; Zdeňka Bendová
Journal:  Mol Neurobiol       Date:  2020-09-22       Impact factor: 5.590

Review 5.  Dual- and triple-acting agents for treating core and co-morbid symptoms of major depression: novel concepts, new drugs.

Authors:  Mark J Millan
Journal:  Neurotherapeutics       Date:  2009-01       Impact factor: 7.620

6.  Regulation of glutamatergic signalling by PACAP in the mammalian suprachiasmatic nucleus.

Authors:  Stephan Michel; Jason Itri; Jung H Han; Kathryn Gniotczynski; Christopher S Colwell
Journal:  BMC Neurosci       Date:  2006-02-16       Impact factor: 3.288

7.  A point mutation in the ion conduction pore of AMPA receptor GRIA3 causes dramatically perturbed sleep patterns as well as intellectual disability.

Authors:  Benjamin Davies; Laurence A Brown; Ondrej Cais; Jake Watson; Amber J Clayton; Veronica T Chang; Daniel Biggs; Christopher Preece; Polinka Hernandez-Pliego; Jon Krohn; Amarjit Bhomra; Stephen R F Twigg; Andrew Rimmer; Alexander Kanapin; Arjune Sen; Zenobia Zaiwalla; Gil McVean; Russell Foster; Peter Donnelly; Jenny C Taylor; Edward Blair; David Nutt; A Radu Aricescu; Ingo H Greger; Stuart N Peirson; Jonathan Flint; Hilary C Martin
Journal:  Hum Mol Genet       Date:  2017-10-15       Impact factor: 6.150

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.